HOME
ABOUT MORSE
The Team
Careers
SERVICES
Our Services
Comprehensive Market Access Launch Strategy
Market Access Landscape Analysis
HTA Planning and Reimbursement Evidence Strategy
Negotiation & Stakeholder Engagement Strategy
Portfolio & Life Cycle Strategy
Expert-Led Training & Customized Workshops
REPORTS
NEW – Order CRaFT 2025
DRD Market Access Trends & Insights
Oncology Market Access Trends & Insights
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
From Model to Market (MORSE x CCX Workshop)
LINKS
CONTACT US
HOME
ABOUT MORSE
The Team
Careers
SERVICES
Our Services
Comprehensive Market Access Launch Strategy
Market Access Landscape Analysis
HTA Planning and Reimbursement Evidence Strategy
Negotiation & Stakeholder Engagement Strategy
Portfolio & Life Cycle Strategy
Expert-Led Training & Customized Workshops
REPORTS
NEW – Order CRaFT 2025
DRD Market Access Trends & Insights
Oncology Market Access Trends & Insights
NEWS
MORSE Signals
MORSE Wire
Publications
What’s New
EVENTS
From Model to Market (MORSE x CCX Workshop)
LINKS
CONTACT US
Radiopharmaceutical
All the posts published.
New INESSS Evaluation Fee Schedule
June 2, 2021
-
Market Access News
,
Publications
-
Posted by
Patrick Manfred
Author: Patrick Manfred, Vice-President, TACT Conseil, Quebec Market Access Expert Date: June 2, 2021 A proposal to modify the current regulation framing the fees payable to the Institut national d'excellence en santé (INESSS) to complete a scientific evaluation of a drug and/or a stable blood product was published in Part 2 of the Quebec Official Gazette, on March 18, 2021. If the Quebec government does not deviate from…
Read More →
Radiopharmaceutical - Info and details on - MORSE Consulting Inc.
Learn More
Learn More